Adjusted Profitability and EPS Growth
Adjusted EBITDA of $285M in Q3 and adjusted EBITDA margin of 10.9% (Q3 and YTD). Net income $200M (+7% YoY); adjusted net income $215M (+9% YoY). Diluted EPS $1.63 (+~12% YoY); adjusted diluted EPS $1.77 (+~14% YoY).
Strong Cash Generation and Balance Sheet
Free cash flow for Q3 of $248M (cash from operations $261M less $13M CapEx). Cash on hand $882M, net debt $3.1B, net leverage ~2.5x adjusted EBITDA (TTM).
Record Year-End Backlog and Growing Pipeline
Ended calendar year with a record year-end backlog >$38B (up ~2% YoY). Qualified pipeline for FY2027 nearly $53B, up ~12% YoY (national security +12%, civil +10%).
Cost Reduction Actions Completed
Completed cost actions that reduced run-rate spend by ~ $150M; actions largely executed in the quarter and set to benefit profitability next fiscal year.
Transition to Outcome-Based and Fixed-Price Work
Successfully transitioned majority of Thunderdome task orders to include fixed-price components and won nearly $100M of fixed-price work to expand Thunderdome across the Department of War, supporting medium- to long-term margin expansion.
Productization and AI/Cyber Momentum
Launched Velox Reverser (AI-native malware reverse engineering) to general availability for federal and commercial customers — reduces malware analysis from days to minutes and supports the company's AI/cyber growth vector.
Significant Strategic Partnership with a16z
Announced first-ever a16z technology acceleration partnership for governments and commitment to deploy up to $400M into a16z's late-stage venture fund to co-create commercial tech for government missions.
Notable Contract Wins and National Security Expansion
Awarded a $99M Navy contract (Military Sealift Command) to deliver global shipboard wireless capabilities (LEO satellites, advanced Wi‑Fi, 5G). Additional expansions with Navy PEO for unmanned/autonomous systems and visual object localization work.
Capital Deployment and Shareholder Returns
Deployed $195M in the quarter: $125M in share repurchases (avg $95.16; ~1% of shares), $67M in dividends. Board approved quarterly dividend of $0.59 per share. Continued opportunistic capital allocation while preserving balance sheet strength.
Tax Rate Improvement Driving EPS Benefit
Change in tax estimate increased R&D tax credit and FDII qualification, reducing effective tax rate and providing an incremental ~$0.47 benefit to ADEPS for the full fiscal year, with a meaningful portion expected to be recurring.